Trials / Completed
CompletedNCT00715416
PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents
Balloon Angioplasty vs. Primary Stenting of Femoropopliteal Arteries Using Self-Expandable Nitinol Stents - a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Vienna General Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The investigators evaluated whether primary implantation of a self-expanding nitinol stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nitinol stent | Interventions are performed percutaneously from either an antegrade or an over-the-bifurcation approach. After insertion of an 6 French sheath, 5000 IU of heparin are administered intra-arterially. After passage of the stenosis/occlusion with the guide wire, patients are randomized to either PTA or primary stent implantation. For standardized documentation of the lesion morphology and comparability during follow-up, a ruler is fixed at the patients thigh with the distal end exactly overlapping at the upper edge of the patella. As a bail-out procedure in the PTA group, stent placement is performed in cases with a residual stenosis of more than 30% in the worst view angiogram. |
| PROCEDURE | Nitinol Stent Placement | Balloon angioplasty compared to primary stent implantation for long segment superficial femoral artery lesions |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2008-02-01
- Completion
- 2008-02-01
- First posted
- 2008-07-15
- Last updated
- 2008-07-15
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT00715416. Inclusion in this directory is not an endorsement.